2QEI - Header Asymmetric Unit

HEADER TRANSPORT PROTEIN 25-JUN-07 2QEI

TITLE CRYSTAL STRUCTURE ANALYSIS OF LEUT COMPLEXED WITH L-ALANINE, SODIUM, TITLE 2 AND CLOMIPRAMINE

COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSPORTER; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: AQUIFEX AEOLICUS; SOURCE 3 ORGANISM_TAXID: 224324; SOURCE 4 STRAIN: VF5; SOURCE 5 GENE: SNF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: C41(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET16B

KEYWDS MEMBRANE PROTEIN, NEUROTRANSMITTER SODIUM SYMPORTER, OCCLUDED, KEYWDS 2 TRICYCLIC ANTIDEPRESSANT, INHIBITOR, TRANSMEMBRANE, TRANSPORT, KEYWDS 3 TRANSPORT PROTEIN

EXPDTA X-RAY DIFFRACTION

AUTHOR S.K.SINGH,A.YAMASHITA,E.GOUAUX

REVDAT 4 13-JUL-11 2QEI 1 VERSN REVDAT 3 24-FEB-09 2QEI 1 VERSN REVDAT 2 08-JAN-08 2QEI 1 JRNL REVDAT 1 21-AUG-07 2QEI 0

JRNL AUTH S.K.SINGH,A.YAMASHITA,E.GOUAUX JRNL TITL ANTIDEPRESSANT BINDING SITE IN A BACTERIAL HOMOLOGUE OF JRNL TITL 2 NEUROTRANSMITTER TRANSPORTERS. JRNL REF NATURE V. 448 952 2007 JRNL REFN ISSN 0028-0836 JRNL PMID 17687333 JRNL DOI 10.1038/NATURE06038

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.YAMASHITA,S.K.SINGH,T.KAWATE,Y.JIN,E.GOUAUX REMARK 1 TITL CRYSTAL STRUCTURE OF A BACTERIAL HOMOLOGUE OF REMARK 1 TITL 2 NA+/CL--DEPENDENT NEUROTRANSMITTER TRANSPORTERS REMARK 1 REF NATURE V. 437 215 2005 REMARK 1 REFN ISSN 0028-0836 REMARK 1 PMID 16041361 REMARK 1 DOI 10.1038/NATURE03978

REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2131364.670 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.6 REMARK 3 NUMBER OF REFLECTIONS : 47143 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2356 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.97 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 55.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4629 REMARK 3 BIN R VALUE (WORKING SET) : 0.2380 REMARK 3 BIN FREE R VALUE : 0.2650 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 222 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4037 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 152 REMARK 3 SOLVENT ATOMS : 100 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.66000 REMARK 3 B22 (A**2) : -4.12000 REMARK 3 B33 (A**2) : -8.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.61000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.76 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.280 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.970 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.880 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.880 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 65.90 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : B REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : B REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : ION.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 STRUCTURE IN ASYMMETRIC UNIT STARTS AT K4 BECAUSE OF DISORDER. REMARK 3 RESIDUES K4, E129, D158, H510, E511, S612, AND L516 ARE MODELED REMARK 3 AS ALANINE BECAUSE OF DISORDER. N133, A134, V517, P518, R519 ARE REMARK 3 NOT MODELED BECAUSE OF DISORDER.

REMARK 4 REMARK 4 2QEI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-AUG-07. REMARK 100 THE RCSB ID CODE IS RCSB043497.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52516 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.6 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.04500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 34.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 54.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.32300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ID 2Q6H REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17-22% PEG MME 550, 200 MM NACL, 100 REMARK 280 MM HEPES-NAOH, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 44.89350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.01350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 44.89350 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 43.01350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 REMARK 300 THE BIOLOGICAL ASSEMBLY MIGHT NOT BE PHYSIOLOGICALLY REMARK 300 RELEVANT MAINLY BECAUSE OF THE RESULTS AUTHORS OBTAINED REMARK 300 IN SOLUTION. THE ACTUAL RESIDUES IN THE RELEVANT REMARK 300 TRANSMEMBRANE DOMAINS (TM9 AND TM12) ARE NOT CONSERVED REMARK 300 IN THE EUKARYOTIC HOMOLOGUES. AUTHORS ARE NOT 100% SURE REMARK 300 BECAUSE CROSSLINKING THE PROTEIN IN A LIPID BILAYER REMARK 300 HAS NOT BEEN PERFORMED.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 6800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 81.27966 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 81.21464

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 VAL A 3 REMARK 465 ASN A 133 REMARK 465 ALA A 134 REMARK 465 VAL A 517 REMARK 465 PRO A 518 REMARK 465 ARG A 519

REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 4 CG CD CE NZ REMARK 470 GLU A 129 CG CD OE1 OE2 REMARK 470 ASP A 158 CG OD1 OD2 REMARK 470 HIS A 510 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 511 CG CD OE1 OE2 REMARK 470 SER A 512 OG REMARK 470 LEU A 516 CG CD1 CD2

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 54 -55.16 -131.29 REMARK 500 PRO A 160 48.65 -77.90 REMARK 500 PHE A 235 4.69 -59.86 REMARK 500 ILE A 297 -79.07 -97.18 REMARK 500 LYS A 398 -1.74 81.22 REMARK 500 THR A 409 -68.91 -123.50 REMARK 500 TYR A 471 -48.33 -136.70 REMARK 500 MET A 476 1.13 -63.09 REMARK 500 GLU A 477 -13.24 -143.14 REMARK 500 REMARK 500 REMARK: NULL

REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE AUTHORS STATE THAT C2 NUMBERING IS IN CRYSTALLOGRAPHIC REMARK 600 NOTATION AND IT IS THE SAME AS C3 NUMBERING IN IUPAC. REMARK 600 REGARDING THE BOND ORDER DIFFERENCE FOR THE C5-C6 BOND, REMARK 600 THE AUTHORS USED THE TOPOLOGY AND PARAMETER FILES DERIVED REMARK 600 FROM THE SMALL MOLECULE CRYSTAL STRUCTURES OF CLOMIPRAMINE REMARK 600 AND IMIPRAMINE RATHER THAN THEORETICAL VALUES.

REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 751 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 VAL A 23 O REMARK 620 2 GLY A 20 O 98.1 REMARK 620 3 SER A 355 OG 99.6 84.0 REMARK 620 4 THR A 354 OG1 112.2 90.4 148.2 REMARK 620 5 ALA A 351 O 94.4 167.3 95.6 83.3 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 752 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 254 O REMARK 620 2 ASN A 286 OD1 87.5 REMARK 620 3 ASN A 27 OD1 173.8 87.7 REMARK 620 4 ALA A 601 OXT 95.4 163.9 90.3 REMARK 620 5 ALA A 22 O 82.8 86.1 100.7 78.6 REMARK 620 6 THR A 254 OG1 81.0 91.8 95.3 104.2 163.7 REMARK 620 N 1 2 3 4 5

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BOG A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BOG A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BOG A 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BOG A 704 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BOG A 705 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 751 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 752 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ALA A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CXX A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CXX A 802

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2A65 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH L-LEUCINE AND SODIUM REMARK 900 RELATED ID: 2Q6H RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH L-LEUCINE, SODIUM, AND REMARK 900 CLOMIPRAMINE REMARK 900 RELATED ID: 2Q72 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH L-LEUCINE, SODIUM, AND REMARK 900 IMIPRAMINE REMARK 900 RELATED ID: 2QB4 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH L-LEUCINE, SODIUM, AND REMARK 900 DESIPRAMINE

DBREF 2QEI A 1 513 UNP O67854 O67854_AQUAE 1 513

SEQADV 2QEI GLY A 514 UNP O67854 CLONING ARTIFACT SEQADV 2QEI THR A 515 UNP O67854 CLONING ARTIFACT SEQADV 2QEI LEU A 516 UNP O67854 CLONING ARTIFACT SEQADV 2QEI VAL A 517 UNP O67854 CLONING ARTIFACT SEQADV 2QEI PRO A 518 UNP O67854 CLONING ARTIFACT SEQADV 2QEI ARG A 519 UNP O67854 CLONING ARTIFACT

SEQRES 1 A 519 MET GLU VAL LYS ARG GLU HIS TRP ALA THR ARG LEU GLY SEQRES 2 A 519 LEU ILE LEU ALA MET ALA GLY ASN ALA VAL GLY LEU GLY SEQRES 3 A 519 ASN PHE LEU ARG PHE PRO VAL GLN ALA ALA GLU ASN GLY SEQRES 4 A 519 GLY GLY ALA PHE MET ILE PRO TYR ILE ILE ALA PHE LEU SEQRES 5 A 519 LEU VAL GLY ILE PRO LEU MET TRP ILE GLU TRP ALA MET SEQRES 6 A 519 GLY ARG TYR GLY GLY ALA GLN GLY HIS GLY THR THR PRO SEQRES 7 A 519 ALA ILE PHE TYR LEU LEU TRP ARG ASN ARG PHE ALA LYS SEQRES 8 A 519 ILE LEU GLY VAL PHE GLY LEU TRP ILE PRO LEU VAL VAL SEQRES 9 A 519 ALA ILE TYR TYR VAL TYR ILE GLU SER TRP THR LEU GLY SEQRES 10 A 519 PHE ALA ILE LYS PHE LEU VAL GLY LEU VAL PRO GLU PRO SEQRES 11 A 519 PRO PRO ASN ALA THR ASP PRO ASP SER ILE LEU ARG PRO SEQRES 12 A 519 PHE LYS GLU PHE LEU TYR SER TYR ILE GLY VAL PRO LYS SEQRES 13 A 519 GLY ASP GLU PRO ILE LEU LYS PRO SER LEU PHE ALA TYR SEQRES 14 A 519 ILE VAL PHE LEU ILE THR MET PHE ILE ASN VAL SER ILE SEQRES 15 A 519 LEU ILE ARG GLY ILE SER LYS GLY ILE GLU ARG PHE ALA SEQRES 16 A 519 LYS ILE ALA MET PRO THR LEU PHE ILE LEU ALA VAL PHE SEQRES 17 A 519 LEU VAL ILE ARG VAL PHE LEU LEU GLU THR PRO ASN GLY SEQRES 18 A 519 THR ALA ALA ASP GLY LEU ASN PHE LEU TRP THR PRO ASP SEQRES 19 A 519 PHE GLU LYS LEU LYS ASP PRO GLY VAL TRP ILE ALA ALA SEQRES 20 A 519 VAL GLY GLN ILE PHE PHE THR LEU SER LEU GLY PHE GLY SEQRES 21 A 519 ALA ILE ILE THR TYR ALA SER TYR VAL ARG LYS ASP GLN SEQRES 22 A 519 ASP ILE VAL LEU SER GLY LEU THR ALA ALA THR LEU ASN SEQRES 23 A 519 GLU LYS ALA GLU VAL ILE LEU GLY GLY SER ILE SER ILE SEQRES 24 A 519 PRO ALA ALA VAL ALA PHE PHE GLY VAL ALA ASN ALA VAL SEQRES 25 A 519 ALA ILE ALA LYS ALA GLY ALA PHE ASN LEU GLY PHE ILE SEQRES 26 A 519 THR LEU PRO ALA ILE PHE SER GLN THR ALA GLY GLY THR SEQRES 27 A 519 PHE LEU GLY PHE LEU TRP PHE PHE LEU LEU PHE PHE ALA SEQRES 28 A 519 GLY LEU THR SER SER ILE ALA ILE MET GLN PRO MET ILE SEQRES 29 A 519 ALA PHE LEU GLU ASP GLU LEU LYS LEU SER ARG LYS HIS SEQRES 30 A 519 ALA VAL LEU TRP THR ALA ALA ILE VAL PHE PHE SER ALA SEQRES 31 A 519 HIS LEU VAL MET PHE LEU ASN LYS SER LEU ASP GLU MET SEQRES 32 A 519 ASP PHE TRP ALA GLY THR ILE GLY VAL VAL PHE PHE GLY SEQRES 33 A 519 LEU THR GLU LEU ILE ILE PHE PHE TRP ILE PHE GLY ALA SEQRES 34 A 519 ASP LYS ALA TRP GLU GLU ILE ASN ARG GLY GLY ILE ILE SEQRES 35 A 519 LYS VAL PRO ARG ILE TYR TYR TYR VAL MET ARG TYR ILE SEQRES 36 A 519 THR PRO ALA PHE LEU ALA VAL LEU LEU VAL VAL TRP ALA SEQRES 37 A 519 ARG GLU TYR ILE PRO LYS ILE MET GLU GLU THR HIS TRP SEQRES 38 A 519 THR VAL TRP ILE THR ARG PHE TYR ILE ILE GLY LEU PHE SEQRES 39 A 519 LEU PHE LEU THR PHE LEU VAL PHE LEU ALA GLU ARG ARG SEQRES 40 A 519 ARG ASN HIS GLU SER ALA GLY THR LEU VAL PRO ARG

HET BOG A 701 20 HET BOG A 702 20 HET BOG A 703 20 HET BOG A 704 20 HET BOG A 705 20 HET NA A 751 1 HET NA A 752 1 HET ALA A 601 6 HET CXX A 801 22 HET CXX A 802 22

HETNAM BOG B-OCTYLGLUCOSIDE HETNAM NA SODIUM ION HETNAM ALA ALANINE HETNAM CXX 3-(3-CHLORO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N- HETNAM 2 CXX DIMETHYLPROPAN-1-AMINE

HETSYN CXX 3-CHLORO-5-(3-(DIMETHYLAMINO)PROPYL)-10,11-DIHYDRO-5H- HETSYN 2 CXX DIBENZ[B,F]AZEPINE

FORMUL 2 BOG 5(C14 H28 O6) FORMUL 7 NA 2(NA 1+) FORMUL 9 ALA C3 H7 N O2 FORMUL 10 CXX 2(C19 H23 CL N2) FORMUL 12 HOH *100(H2 O)

HELIX 1 1 THR A 10 VAL A 23 1 14 HELIX 2 2 GLY A 24 LEU A 29 1 6 HELIX 3 3 LEU A 29 ASN A 38 1 10 HELIX 4 4 GLY A 40 VAL A 54 1 15 HELIX 5 5 VAL A 54 GLN A 72 1 19 HELIX 6 6 THR A 76 TRP A 85 1 10 HELIX 7 7 ASN A 87 VAL A 95 1 9 HELIX 8 8 VAL A 95 VAL A 124 1 30 HELIX 9 9 ASP A 136 GLY A 153 1 18 HELIX 10 10 SER A 165 ILE A 184 1 20 HELIX 11 11 ARG A 185 GLY A 190 1 6 HELIX 12 12 GLY A 190 PHE A 214 1 25 HELIX 13 13 ALA A 223 TRP A 231 1 9 HELIX 14 14 ASP A 240 SER A 256 1 17 HELIX 15 15 GLY A 260 SER A 267 1 8 HELIX 16 16 ILE A 275 ILE A 292 1 18 HELIX 17 17 LEU A 293 ALA A 317 1 25 HELIX 18 18 PHE A 320 ILE A 325 1 6 HELIX 19 19 ILE A 325 SER A 332 1 8 HELIX 20 20 GLY A 336 GLU A 370 1 35 HELIX 21 21 SER A 374 LEU A 396 1 23 HELIX 22 22 LYS A 398 ALA A 407 1 10 HELIX 23 23 THR A 409 TRP A 425 1 17 HELIX 24 24 GLY A 428 ARG A 438 1 11 HELIX 25 25 ARG A 446 TYR A 454 1 9 HELIX 26 26 TYR A 454 TYR A 471 1 18 HELIX 27 27 THR A 482 GLY A 514 1 33

SHEET 1 A 2 GLU A 217 THR A 218 0 SHEET 2 A 2 GLY A 221 THR A 222 -1 O GLY A 221 N THR A 218

LINK NA NA A 751 O VAL A 23 1555 1555 2.17 LINK NA NA A 751 O GLY A 20 1555 1555 2.23 LINK NA NA A 751 OG SER A 355 1555 1555 2.39 LINK NA NA A 751 OG1 THR A 354 1555 1555 2.37 LINK NA NA A 751 O ALA A 351 1555 1555 2.29 LINK NA NA A 752 O THR A 254 1555 1555 2.28 LINK NA NA A 752 OD1 ASN A 286 1555 1555 2.51 LINK NA NA A 752 OD1 ASN A 27 1555 1555 2.28 LINK NA NA A 752 OXT ALA A 601 1555 1555 2.58 LINK NA NA A 752 O ALA A 22 1555 1555 2.18 LINK NA NA A 752 OG1 THR A 254 1555 1555 2.46

SITE 1 AC1 7 ARG A 142 GLU A 146 ARG A 446 TYR A 448 SITE 2 AC1 7 HOH A 836 HOH A 892 HOH A 893 SITE 1 AC2 4 PHE A 167 ILE A 170 ARG A 438 HOH A 860 SITE 1 AC3 7 PRO A 164 LEU A 166 TYR A 169 HIS A 391 SITE 2 AC3 7 PHE A 395 BOG A 704 HOH A 876 SITE 1 AC4 5 HIS A 391 LEU A 392 PHE A 488 BOG A 703 SITE 2 AC4 5 BOG A 705 SITE 1 AC5 7 ILE A 161 LYS A 163 LEU A 396 THR A 479 SITE 2 AC5 7 VAL A 483 TRP A 484 BOG A 704 SITE 1 AC6 6 GLY A 20 VAL A 23 GLY A 24 ALA A 351 SITE 2 AC6 6 THR A 354 SER A 355 SITE 1 AC7 5 ALA A 22 ASN A 27 THR A 254 ASN A 286 SITE 2 AC7 5 ALA A 601 SITE 1 AC8 11 ASN A 21 ALA A 22 GLY A 24 LEU A 25 SITE 2 AC8 11 GLY A 26 ASN A 27 TYR A 108 PHE A 253 SITE 3 AC8 11 THR A 254 SER A 256 NA A 752 SITE 1 AC9 5 ARG A 30 GLN A 34 PHE A 320 ASP A 401 SITE 2 AC9 5 ASP A 404 SITE 1 BC1 6 SER A 181 ARG A 185 GLY A 190 ARG A 193 SITE 2 BC1 6 PHE A 194 PHE A 350

CRYST1 89.787 86.027 81.659 90.00 95.98 90.00 C 1 2 1 4

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.011137 0.000000 0.001167 0.00000

SCALE2 0.000000 0.011624 0.000000 0.00000

SCALE3 0.000000 0.000000 0.012313 0.00000